Extrapelvic Urinary Extravasation Caused by Retroperitoneal Metastasis of Pulmonary Squamous Cell Carcinoma: A Case Report.
증례보고
1/5 보강
A 52-year-old man with pulmonary squamous cell carcinoma, clinically staged as cTxN3M1c (stage IVB), received four cycles of first-line chemotherapy with cisplatin plus TS-1 followed by seven cycles o
APA
Taguchi M, Kiwamoto T, et al. (2026). Extrapelvic Urinary Extravasation Caused by Retroperitoneal Metastasis of Pulmonary Squamous Cell Carcinoma: A Case Report.. Cureus, 18(2), e102774. https://doi.org/10.7759/cureus.102774
MLA
Taguchi M, et al.. "Extrapelvic Urinary Extravasation Caused by Retroperitoneal Metastasis of Pulmonary Squamous Cell Carcinoma: A Case Report.." Cureus, vol. 18, no. 2, 2026, pp. e102774.
PMID
41783867
Abstract
A 52-year-old man with pulmonary squamous cell carcinoma, clinically staged as cTxN3M1c (stage IVB), received four cycles of first-line chemotherapy with cisplatin plus TS-1 followed by seven cycles of second-line nivolumab. Subsequent imaging revealed progressive enlargement of cervical lymph nodes, left adrenal metastasis, and retroperitoneal metastases. Over several days, he developed left flank and back pain and presented to the emergency department. An emergent contrast-enhanced abdominal computed tomography (CT) demonstrated contrast extravasation from the upper left ureter, left ureteral obstruction caused by retroperitoneal metastasis, and mild hydronephrosis. He was diagnosed with extrapelvic urinary extravasation and underwent placement of a polymeric double-J ureteral stent. His pain resolved promptly thereafter, allowing initiation of third-line chemotherapy. Extrapelvic urinary extravasation due to retroperitoneal dissemination of pulmonary squamous cell carcinoma is extremely rare, and no prior cases were identified in our literature search. Nevertheless, recognizing this condition as a potential differential diagnosis for flank or back pain during disease relapse may facilitate early intervention, support continuation of systemic therapy, and ultimately improve quality of life.
같은 제1저자의 인용 많은 논문 (4)
- A Case of Tegafur-Uracil-Induced Interstitial Lung Disease Presenting as Hypersensitivity Pneumonitis.
- Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-matched cohort study.
- Markedly Melanin-Pigmented Paraganglioma Associated With Decreased Dopa-Decarboxylase Expression.
- Resectable Pancreatic Adenocarcinomas following Neoadjuvant Chemotherapy with Gemcitabine Plus S-1: Two Case Reports of Opposite Oncological Outcomes.